Tuberculosis
Tuberculosis Meningitis
TB Drug Rifampin
TB Drug Isoniazid

U.S. Public Health Service Tuberculosis Guidelines

Liver Toxicity Among HIV Positive African Patients on HAART is Associated with Tuberculosis Therapy and Hepatitis B Coinfection    - 7/07/07

HIV Positive People May Need Longer Treatment for Tuberculosis    - 6/15/07

Risk of TB-associated Immune Reconstitution Disease Is High in South African Patients Initiating Antiretroviral Therapy with Low Baseline CD4 Cell Counts  - 3/16/07

High Mortality Due to Multidrug-resistant Tuberculosis among HIV Positive Patients in South Africa - 8/29/06

Glutathione and Growth Inhibition of Mycobacterium Tuberculosis in Healthy and HIV-infected Subjects - 4/11/06

Statement on World TB Day by Christine Sizemore, PhD, Barbara Laughon, PhD and Anthony S. Fauci, MD - 3/28/06

A Portfolio of Anti-TB Drug Candidates - 3/28/06

A Fact Sheet on the TB Alliance and GlaxoSmithKline Partnership - 3/28/06

Tuberculosis in the US - 3/28/06

Tuberculosis: An Easy-t0-read Guide for Adults and Adolescents with HIV - 3/28/06

HIV and Hepatitis.com Articles on Tuberculosis- 3/28/06

What Is the Optimal TB Therapy Duration for Preventing Relapse in HIV Patients on HAART? - 2/24/06

Once Daily Regimen of Saquinavir, Ritonavir, Didanosine, and Lamivudine in HIV Patients on Standard Tuberculosis Therapy - 11/02/05

Bayer Offers Moxifloxacin, a Promising New Antibiotic in the Fight against TB and AIDS - 10/19/05

Appropriate Dose of Efavirenz Is Unclear for HIV Patients with Tuberculosis Receiving HAART and Rifampicin - 9/23/05

The Importance of Recent Infection with Mycobacterium Tuberculosis in an Area with High HIV Prevalence - 7/11/05

Outcome of Tuberculosis in HIV Positive Children - 7/06/05

Promising New Anti-tuberculosis Drug PA-824 Enters Clinical Trials - 6/15/05

Immune Reconstitution Disease Is Associated with Mycobacterial Infections in HIV Patients Receiving Antiretrovirals - 6/08/05

Tuberculosis: An Old Disease Needs New Cures - 3/28/05

Global Campaign Against Tuberculosis Makes Headway, but AIDS and Africa Have Big Problems - 3/25/05

Toward Defining the Incidence, Risk Factors and Long-term Outcome of a Unique, HAART-related Disease: Immune Reconstitution Inflammatory Syndrome (IRIS) - 3/11/05

Short-Course Therapy with Rifampin plus Isoniazid, Compared with Standard Therapy with Isoniazid, for Latent Tuberculosis Infection - 2/14/05

Incidence of Immune Reconstitution Syndrome in HIV-Tuberculosis Coinfected Patients in India - 2/11/05

Roche Issues Drug Interaction Warning on Hepatocellular Toxicity in Healthy Volunteers Receiving TB Drug Rifampin and Saquinavir/Ritonavir - 2/09/05

Cotrimoxazole Prophylaxis for TB Effectively Reduces Adult Death Rates in Rural South Africa - 2/09/05

Pharmacokinetic Study of Tenofovir Combined with Rifampin in Healthy Volunteers - 2/07/05

Effectiveness of Generic Fixed-Dose Combinations of HAART in India - 2/07/05

The Risk of Acquiring Tuberculosis (TB) Increases Rapidly After Infection with HIV - 1/05/05

Implications of the Increased Risk of Tuberculosis (TB) During the Course of HIV Infection - 1/05/05